Pure Global

"Sysmecon" automatic blood coagulation analyzer - Taiwan Registration bc184aced35979837bb6ac0aa31ae08b

Access comprehensive regulatory information for "Sysmecon" automatic blood coagulation analyzer in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number bc184aced35979837bb6ac0aa31ae08b and manufactured by SYSMEX CORPORATION;; SYSMEX CORPORATION Kakogawa Factory. The authorized representative in Taiwan is SYSMEX TAIWAN CO., LTD..

This page provides complete technical specifications, regulatory compliance details, 3 companies making similar products including SYSMEX CORPORATION;; SYSMEX CORPORATION, I-SQUARE, SYSMEX CORPORATION, I-SQUARE, and 5 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
3 Competitors
5 Recent Registrations
bc184aced35979837bb6ac0aa31ae08b
Registration Details
Taiwan FDA Registration: bc184aced35979837bb6ac0aa31ae08b
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Sysmecon" automatic blood coagulation analyzer
TW: โ€œๅธŒๆฃฎ็พŽๅบทโ€ ๅ…จ่‡ชๅ‹•่ก€ๆถฒๅ‡ๅ›บๅˆ†ๆžๅ„€
Risk Class 2

Registration Details

bc184aced35979837bb6ac0aa31ae08b

DHA05602831402

Company Information

Product Details

This instrument is an in vitro diagnostic analyzer for sampling and analyzing human blood plasma components with anticoagulant (sodium citrate). Fibrin differentiation (FDP) analysis can be performed using plasma and serological samples.

B Hematology, pathology, and genetics

B.5425 Versatile system for in vitro agglutination studies

import

Dates and Status

Mar 24, 2016

Mar 24, 2026